Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Zoa Corporation (3375:JPX), powered by AI.
Zoa Corporation is currently trading at ¥1,606. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Zoa Corporation on Alpha Lenz.
Zoa Corporation's P/E ratio is 6.8.
“Zoa Corporation trades at a P/E of 6.8 (undervalued) with solid ROE of 10.5%.”
Ask for details →Zoa Corporation is a prominent player in the biomaterials sector, specializing in innovative solutions for sustainable living and healthcare advancements. With a focus on research and development, Zoa Corporation is driven by its mission to create eco-friendly materials that can substitute traditional plastics, catering to industries aiming to reduce their carbon footprint. The company produces a range of biodegradable alternatives impacting sectors such as packaging, automotive, and consumer goods, thereby supporting a circular economy initiative. Additionally, Zoa Corporation is actively involved in collaborations with healthcare organizations to design biomaterials that can be utilized in medical devices and tissue engineering, promoting regenerative medicine. As the demand for sustainable practices continues to rise globally, Zoa Corporation plays a crucial role in advancing the biomaterials industry and offers significant contributions toward environmental sustainability.
“Zoa Corporation trades at a P/E of 6.8 (undervalued) with solid ROE of 10.5%.”
Ask for details →Zoa Corporation (ticker: 3375) is a company listed on JPX in the Technology sector (Electronics & Computer Distribution). It has approximately 70 employees. Market cap is $2.0B.
The current price is 1,606 with a P/E ratio of 6.79x and P/B of 0.69x.
ROE is 10.53% and operating margin is 4.62%. Annual revenue is $9.3B.